DK175815B1 - Lagerfaste, sterile, pyrogen-frie, injicerbare anthracyclin-glycosid-oplösninger og fremgangsmåde til deres fremstilling - Google Patents

Lagerfaste, sterile, pyrogen-frie, injicerbare anthracyclin-glycosid-oplösninger og fremgangsmåde til deres fremstilling Download PDF

Info

Publication number
DK175815B1
DK175815B1 DK198706352A DK635287A DK175815B1 DK 175815 B1 DK175815 B1 DK 175815B1 DK 198706352 A DK198706352 A DK 198706352A DK 635287 A DK635287 A DK 635287A DK 175815 B1 DK175815 B1 DK 175815B1
Authority
DK
Denmark
Prior art keywords
hcl
doxorubicin
solution
stability
epirubicin
Prior art date
Application number
DK198706352A
Other languages
Danish (da)
English (en)
Other versions
DK635287A (da
DK635287D0 (da
Inventor
Diego Oldani
Gaetano Gatti
Giuseppe Bottoni
Carlo Confalonieri
Luciano Gambini
Roberto De Ponti
Original Assignee
Pharmacia Italia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26291656&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK175815(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB868629193A external-priority patent/GB8629193D0/en
Application filed by Pharmacia Italia Spa filed Critical Pharmacia Italia Spa
Publication of DK635287D0 publication Critical patent/DK635287D0/da
Publication of DK635287A publication Critical patent/DK635287A/da
Application granted granted Critical
Publication of DK175815B1 publication Critical patent/DK175815B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK198706352A 1986-12-05 1987-12-03 Lagerfaste, sterile, pyrogen-frie, injicerbare anthracyclin-glycosid-oplösninger og fremgangsmåde til deres fremstilling DK175815B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8629193 1986-12-05
GB868629193A GB8629193D0 (en) 1986-12-05 1986-12-05 Injectable ready-to-use solutions
US6465387A 1987-06-22 1987-06-22
US6465387 1987-06-22

Publications (3)

Publication Number Publication Date
DK635287D0 DK635287D0 (da) 1987-12-03
DK635287A DK635287A (da) 1988-06-06
DK175815B1 true DK175815B1 (da) 2005-03-07

Family

ID=26291656

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198706352A DK175815B1 (da) 1986-12-05 1987-12-03 Lagerfaste, sterile, pyrogen-frie, injicerbare anthracyclin-glycosid-oplösninger og fremgangsmåde til deres fremstilling

Country Status (22)

Country Link
EP (4) EP0438183B1 (ja)
JP (1) JP2621255B2 (ja)
KR (2) KR960007861B1 (ja)
CN (1) CN1058391C (ja)
AT (2) ATE240108T1 (ja)
AU (1) AU632036B2 (ja)
BE (1) BE1000540A5 (ja)
CH (1) CH680494A5 (ja)
DE (4) DE3741037A1 (ja)
DK (1) DK175815B1 (ja)
ES (3) ES2039460T3 (ja)
FI (1) FI91710C (ja)
FR (1) FR2607702B1 (ja)
GB (1) GB2200047B (ja)
GR (2) GR871846B (ja)
HK (3) HK39591A (ja)
IT (1) IT1226072B (ja)
NL (1) NL8702914A (ja)
NO (1) NO175802C (ja)
PT (1) PT86285B (ja)
SE (1) SE512881C2 (ja)
SG (1) SG36591G (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8519452D0 (en) * 1985-08-02 1985-09-11 Erba Farmitalia Injectable solutions
DE10300323A1 (de) * 2003-01-09 2004-10-14 Baxter Healthcare S.A. Sicherheitsbehälter mit erhöhter Bruch und Splitterfestigkeit sowie kontaminationsfreier Außenfläche für biologisch aktive Substanzen und Verfahren zu deren Herstellung
CA2446837C (en) * 2001-05-11 2012-01-03 Mitsubishi Pharma Corporation Stable high-concentration injection containing pyrazolone derivative
AU2006213440A1 (en) * 2005-02-11 2006-08-17 Dabur Pharma Limited Stabilized anthracycline glycoside pharmaceutical compositions
EP1814525A2 (en) * 2005-05-11 2007-08-08 Sicor Inc. Stable lyophilized anthracycline glycosides
MX2010001263A (es) * 2007-09-04 2010-10-04 Meiji Seika Kaisha Inyeccion, solucion de inyeccion y preparacion de equipo de inyeccion.
EP2174651A1 (en) * 2008-10-09 2010-04-14 Charité-Universitätsmedizin Berlin (Charité) A polymer-free hydrogel
CN102614118B (zh) * 2012-03-15 2014-04-30 北京协和药厂 注射用盐酸表柔比星制剂的制备方法及制剂
CN111617030B (zh) * 2020-05-22 2021-09-07 广东药科大学 壳寡糖口服液及其在制备减肥药物中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4177264A (en) * 1977-10-17 1979-12-04 Sri International N-benzyl anthracyclines
GB2007645B (en) * 1977-10-17 1982-05-12 Stanford Res Inst Int Benzyl anthracyclines and pharmaceutical compositions containing them
GB2187311B (en) * 1984-07-27 1988-02-10 Ae Plc Automatic vehicle speed control system
GB8426672D0 (en) * 1984-10-22 1984-11-28 Erba Farmitalia Pharmaceutical compositions
GB8519452D0 (en) * 1985-08-02 1985-09-11 Erba Farmitalia Injectable solutions
JPH0655667A (ja) * 1992-08-06 1994-03-01 Nippon Zeon Co Ltd 複合成形体

Also Published As

Publication number Publication date
SG36591G (en) 1991-06-21
FR2607702A1 (fr) 1988-06-10
EP0438183B1 (en) 1995-11-08
DE3752368D1 (de) 2003-06-18
ES2039460T3 (es) 1993-10-01
ES2198424T3 (es) 2004-02-01
ES2082023T3 (es) 1996-03-16
ATE240108T1 (de) 2003-05-15
CN1058391C (zh) 2000-11-15
NL8702914A (nl) 1988-07-01
DE3751589D1 (de) 1995-12-14
DE3777365D1 (de) 1992-04-16
KR880007086A (ko) 1988-08-26
DE3741037A1 (de) 1988-06-09
KR0158672B1 (en) 1998-12-01
IT8722869A0 (it) 1987-12-03
HK1049440A1 (zh) 2003-05-16
EP0438183A1 (en) 1991-07-24
PT86285A (en) 1988-01-01
NO875055L (no) 1988-06-06
FI875340A0 (fi) 1987-12-03
AU8205987A (en) 1988-06-09
EP1283044A3 (en) 2003-05-14
GR871846B (en) 1988-04-01
JP2621255B2 (ja) 1997-06-18
ATE129896T1 (de) 1995-11-15
SE512881C2 (sv) 2000-05-29
DE3751589T2 (de) 1996-05-02
HK39591A (en) 1991-05-31
GR3004303T3 (ja) 1993-03-31
EP0273603A2 (en) 1988-07-06
FI91710C (fi) 1994-08-10
JPS63215633A (ja) 1988-09-08
NO875055D0 (no) 1987-12-03
GB8728313D0 (en) 1988-01-06
EP0273603A3 (en) 1988-07-20
NO175802C (no) 1994-12-14
KR960007861B1 (ko) 1996-06-13
BE1000540A5 (fr) 1989-01-24
DK635287A (da) 1988-06-06
AU632036B2 (en) 1992-12-17
HK1011288A1 (en) 1999-07-09
DK635287D0 (da) 1987-12-03
EP0659435B1 (en) 2003-05-14
PT86285B (pt) 1990-11-07
NO175802B (no) 1994-09-05
IT1226072B (it) 1990-12-10
GB2200047B (en) 1990-11-21
CN87108225A (zh) 1988-09-14
FR2607702B1 (fr) 1991-08-16
EP0659435A1 (en) 1995-06-28
FI91710B (fi) 1994-04-29
FI875340A (fi) 1988-06-06
SE8704849L (sv) 1988-06-06
GB2200047A (en) 1988-07-27
EP0273603B1 (en) 1992-03-11
CH680494A5 (ja) 1992-09-15
SE8704849D0 (sv) 1987-12-03
EP1283044A2 (en) 2003-02-12
DE3752368T2 (de) 2004-02-12

Similar Documents

Publication Publication Date Title
DK175815B1 (da) Lagerfaste, sterile, pyrogen-frie, injicerbare anthracyclin-glycosid-oplösninger og fremgangsmåde til deres fremstilling
SE467520B (sv) Lyofiliserat injektionspreparat, anvaendning daerav foer framstaellning av tumoerbehandlingsmedel samt foerfarande foer framstaellning av en injektionsloesning innehaallande preparatet
DK167557B1 (da) Injicerbar, brugsklar, steril pyrogenfri anthracyclinglycosidoploesning og fremgangsmaade til dens fremstilling
KR101716215B1 (ko) 즉시 주입가능한 젬시타빈 용액
US6107285A (en) Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
KR101487953B1 (ko) 유기용매 무함유 젬시타빈 수용액 조성물
JP6033931B2 (ja) 有機溶媒無含有ゲムシタビン水溶液組成物
BRPI0405798B1 (pt) Processo de eliminação de resíduos alcalinos presentes no 9-((1,3-dihidroxipropan-2-iloxi)metil)-2-amino-1h-purin-6(9h)-ona e apresentação farmacêutica
JP2015000869A (ja) 有機溶媒無含有ゲムシタビン水溶液組成物

Legal Events

Date Code Title Description
PUP Patent expired